Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis
Clinical trial NCT02542787 · COMPLETED
Trial details
- NCT number
- NCT02542787
- Sponsor
- Canbex Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-10-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.